Literature DB >> 9195765

Prevalence and clinical features of chronic daily headache in a headache clinic.

A Srikiatkhachorn1, K Phanthumchinda.   

Abstract

Although chronic daily headache is regarded as a syndrome encountered in headache clinics, clinical characteristics have only rarely been studied and the condition has not been documented in Thailand. To investigate the prevalence as well as clinical features of chronic daily headache in Thai patients, 220 patients visiting Chulalongkorn Headache Clinic were examined. Sixty cases (27.3%) were diagnosed as suffering from chronic daily headache (male to female ratio, 1:5.7). The average age of these patients was 32.7 +/- 9.6 years. Based on the International Headache Society (IHS) criteria, 30% of patients with chronic daily headache could be diagnosed as suffering from migraine and 36.7% from chronic tension-type headache, whereas the remainder had combined features of both headache types and were not classifiable. Diffuse steady pain was the most common headache type reported (65%), however, associated features characteristic of migraine were often noted. These included photophobia (70%), phonophobia (56.7%) and nausea (43%). Thirty-four cases (56.7%) reported that their headache could be aggravated by stress. Daily use of analgesics was reported in 58.3% of cases. We concluded that chronic daily headache is a common problem. Although the mechanism has not been fully clarified, the prevalence of associated psychological factors and analgesic overuse imply their involvement in the pathogenesis of this condition. The criteria of the IHS are not entirely suitable for diagnosis and classification of this disorder, and modification of this classification system is needed.

Entities:  

Mesh:

Year:  1997        PMID: 9195765     DOI: 10.1046/j.1526-4610.1997.3705277.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  14 in total

Review 1.  Headache.

Authors:  T J Steiner; Manuela Fontebasso
Journal:  BMJ       Date:  2002-10-19

Review 2.  Cognitive-behavioral issues in the treatment and management of chronic daily headache.

Authors:  Gay L Lipchik; Justin M Nash
Journal:  Curr Pain Headache Rep       Date:  2002-12

Review 3.  Chronic daily headache in children and adolescents.

Authors:  Shashi S Seshia
Journal:  Curr Pain Headache Rep       Date:  2012-02

Review 4.  Behavioral interventions for tension-type headache: overview of current therapies and recommendation for a self-management model for chronic headache.

Authors:  Donald B Penzien; Jeanetta C Rains; Gay L Lipchik; Thomas L Creer
Journal:  Curr Pain Headache Rep       Date:  2004-12

5.  Children and adolescents with chronic daily headache.

Authors:  Jack Gladstein
Journal:  Curr Pain Headache Rep       Date:  2004-02

6.  Epidemiology and clinical characteristics of chronic daily headache in a clinic-based cohort of Iranian population.

Authors:  Seyed Mohammad Seyed Saadat; Mozaffar Hosseininezhad; Babak Bakhshayesh; Mahsa Hoseini; Mohamadreza Naghipour
Journal:  Neurol Sci       Date:  2013-09-26       Impact factor: 3.307

Review 7.  New daily persistent headache in children and adults.

Authors:  Kenneth J Mack
Journal:  Curr Pain Headache Rep       Date:  2009-02

Review 8.  Pathophysiology of chronic daily headache.

Authors:  A Srikiatkhachorn
Journal:  Curr Pain Headache Rep       Date:  2001-12

9.  Refractory migraine in a headache clinic population.

Authors:  Pablo Irimia; Jose-Alberto Palma; Roberto Fernandez-Torron; Eduardo Martinez-Vila
Journal:  BMC Neurol       Date:  2011-08-01       Impact factor: 2.474

10.  Double-Binding Botulinum Molecule with Reduced Muscle Paralysis: Evaluation in In Vitro and In Vivo Models of Migraine.

Authors:  Anna P Andreou; Charlotte Leese; Rosaria Greco; Chiara Demartini; Eve Corrie; Deniz Simsek; Anna Zanaboni; Ksenia Koroleva; Joseph O Lloyd; Giorgio Lambru; Ciara Doran; Oleg Gafurov; Elizabeth Seward; Rashid Giniatullin; Cristina Tassorelli; Bazbek Davletov
Journal:  Neurotherapeutics       Date:  2020-11-17       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.